Rare diseases
Investigational molecules
Locations
Back to Belgium1 305 clinical trials in Charleroi, Belgium across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of ALXN1850 for Children Aged 2 to 12 with Hypophosphatasia Who Have Not Previously Received Asfotase Alfa Treatment
BelgiumStudy to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations
BelgiumStudy on Posaconazole for Treating Fungal Infections in Children Under 2 Years
BelgiumStudy on Obeticholic Acid for Children with Biliary Atresia After Kasai Procedure
BelgiumStudy on Mosunetuzumab and Lenalidomide for Untreated Follicular Lymphoma Patients
BelgiumStudy on the Effectiveness and Safety of Luveltamab Tazevibulin Compared to Chemotherapy in Women with Relapsed Platinum-resistant Ovarian Cancer
BelgiumStudy of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
BelgiumStudy on Roxadustat for Treating Anemia in Children with Chronic Kidney Disease
BelgiumStudy on the Safety and Effectiveness of GTAEXS617 for Patients with Advanced Solid Tumors
BelgiumStudy of Disitamab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer Expressing HER2
BelgiumStudy on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumStudy on the Effectiveness of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in breast cancer, lung cancer, and head and neck cancers. Studies evaluate novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple trials investigating personalized medicine approaches and biomarker-driven treatments.
Research examining treatments for coronary artery disease and post-cardiac arrest care. Trials focus on innovative stent technologies and antiplatelet therapy optimization.
Emphasis on improving patient outcomes through targeted interventional approaches.
Clinical investigations targeting inflammatory skin conditions and immune-mediated disorders. Studies evaluate novel treatments for psoriasis and other dermatological conditions.
Focus on developing targeted therapies for chronic inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
